These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 775499

  • 1. Central factors in the control of insulin and glucagon secretion.
    Porte D, Woods SC, Chen M, Smith PH, Ensinck JW.
    Pharmacol Biochem Behav; 1975; 3(1 Suppl):127-33. PubMed ID: 775499
    [Abstract] [Full Text] [Related]

  • 2. Evidence of a paracrine role for pancreatic somatostatin in vivo.
    Taborsky GJ.
    Am J Physiol; 1983 Dec; 245(6):E598-603. PubMed ID: 6140853
    [Abstract] [Full Text] [Related]

  • 3. Effect of phentolamine on the somatostatin-induced inhibition of glucagon and insulin secretion.
    Kaneto A, Kajinuma H, Kaneko T, Kosaka K.
    Metabolism; 1978 Aug; 27(8):901-10. PubMed ID: 209286
    [Abstract] [Full Text] [Related]

  • 4. In vivo stimulation of pancreatic hormone secretion by norepinephrine infusion in the dog.
    Ribes G, Trimble ER, Blayac JP, Wollheim CB, Loubatières-Mariani MM.
    Am J Physiol; 1984 Apr; 246(4 Pt 1):E339-43. PubMed ID: 6144271
    [Abstract] [Full Text] [Related]

  • 5. [Effect of somatostatin on pancreatic endocrine--experiment by somatostatin infusion into the pancreaticoduodenal artery in dogs--(author's transl)].
    Nakabayashi H, Yoshimitsu K, Kishitani M, Ueda M, Kawato M.
    Nihon Naibunpi Gakkai Zasshi; 1976 Mar 20; 52(3):218-26. PubMed ID: 786754
    [Abstract] [Full Text] [Related]

  • 6. Sustained oscillations of insulin, glucagon, and somatostatin from the isolated canine pancreas during exposure to a constant glucose concentration.
    Stagner JI, Samols E, Weir GC.
    J Clin Invest; 1980 Apr 20; 65(4):939-42. PubMed ID: 6987271
    [Abstract] [Full Text] [Related]

  • 7. Possible involvement of the cholinergic system in hormonal secretion by the perfused pancreas from ventromedial-hypothalamic lesioned rats.
    Rohner-Jeanrenaud F, Jeanrenaud B.
    Diabetologia; 1981 Mar 20; 20(3):217-22. PubMed ID: 6112185
    [Abstract] [Full Text] [Related]

  • 8. Contribution of neural intrapancreatic non-cholinergic non-adrenergic mechanisms to glucose-induced insulin release in the isolated rat pancreas.
    Weigert N, Dollinger M, Schmid R, Schusdziarra V.
    Diabetologia; 1992 Dec 20; 35(12):1133-9. PubMed ID: 1478364
    [Abstract] [Full Text] [Related]

  • 9. Acetylcholine stimulates insulin, glucagon, and somatostatin release in the perfused chicken pancreas.
    Honey RN, Weir GC.
    Endocrinology; 1980 Oct 20; 107(4):1065-8. PubMed ID: 6105951
    [Abstract] [Full Text] [Related]

  • 10. Glucagon release induced by pancreatic nerve stimulation in the dog.
    Marliss EB, Girardier L, Seydoux J, Wollheim CB, Kanazawa Y, Orci L, Renold AE, Porte D.
    J Clin Invest; 1973 May 20; 52(5):1246-59. PubMed ID: 4349486
    [Abstract] [Full Text] [Related]

  • 11. Effects of a thiazide diuretic (hydroflumethiazide) and a loop diuretic (bumetanide) on the endocrine pancreas: studies in vitro.
    Hermansen K, Schmitz O, Mogensen CE.
    Metabolism; 1985 Aug 20; 34(8):784-9. PubMed ID: 2862565
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ.
    Johnson DG, Ensinck JW, Koerker D, Palmer J, Goodner CJ.
    Endocrinology; 1975 Feb 20; 96(2):370-4. PubMed ID: 1089535
    [Abstract] [Full Text] [Related]

  • 13. Characterization of growth hormone-releasing hormone stimulation of the endocrine pancreas: studies with alpha- and beta-adrenergic and cholinergic antagonists.
    Hermansen K, Kappelgaard AM.
    Acta Endocrinol (Copenh); 1987 Apr 20; 114(4):589-94. PubMed ID: 2883798
    [Abstract] [Full Text] [Related]

  • 14. Effects of hypothalamic factors on insulin and glucagon release from the islets of Langerhans.
    Moltz JH, Dobbs RE, McCann SM, Fawcett CP.
    Endocrinology; 1977 Jul 20; 101(1):196-202. PubMed ID: 324754
    [Abstract] [Full Text] [Related]

  • 15. Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion.
    Mandarino L, Stenner D, Blanchard W, Nissen S, Gerich J, Ling N, Brazeau P, Bohlen P, Esch F, Guillemin R.
    Nature; 1981 May 07; 291(5810):76-7. PubMed ID: 6112710
    [Abstract] [Full Text] [Related]

  • 16. Somatostatin-induced inhibition of insulin secretion from isolated islets of rat pancreas in presence of glucagon.
    Sieradzki J, Schatz H, Nierle C, Pfeiffer EF.
    Horm Metab Res; 1975 Jul 07; 7(4):284-7. PubMed ID: 168138
    [Abstract] [Full Text] [Related]

  • 17. Synthetic pancreatic growth hormone-releasing factor (GRF-40) stimulates the secretion of the endocrine pancreas.
    Hermansen K, Kappelgaard AM, Esmann J, Orskov H.
    Diabetes; 1986 Jan 07; 35(1):119-23. PubMed ID: 2866996
    [Abstract] [Full Text] [Related]

  • 18. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
    Kadowaki S, Taminato T, Chiba T, Nozawa M, Fujita T, Norman AW.
    Endocrinology; 1983 Jun 07; 112(6):2187-92. PubMed ID: 6133743
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of somatostatin analogues on alpha- and beta-cells of the pancreas.
    Taborsky GJ, Smith PH, Porte D.
    Am J Physiol; 1979 Feb 07; 236(2):E123-8. PubMed ID: 369388
    [Abstract] [Full Text] [Related]

  • 20. Changes in insulin, somatostatin, and glucagon secretion during the development of obesity in ventromedial hypothalamic-lesioned rats.
    Seino Y, Seino S, Takemura J, Tsuda K, Nishi S, Ishida H, Seno M, Usami M, Ikeda M, Imura H.
    Endocrinology; 1984 Feb 07; 114(2):457-61. PubMed ID: 6140160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.